Skip to content

To Understand the efficacy of Solanum insanum L.(traditionally used as a substitute of Brihati) and Brihati (Solanum indicum L.)in the management of Ashmari( Renal Stone)

Evaluation of Solanum insanum L. as an alternative to one of the Dashamoola plant Brihati (Solanum indicum L.) - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/08/056894
Enrollment
30
Registered
2023-08-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N202- Calculus of kidney with calculus of ureter

Interventions

None listed

Sponsors

ITRA, Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age of patients- 18 to 60 years of either sex. 2. Kidney and ureteral stone size up to 8 mm.

Exclusion criteria

Exclusion criteria: 1. Urethral stone. 2. Gross Hydronephrosis. 3. Chronic Renal failure. (Sr. Creatinine >2mg/dl will not be included) 4. Cases which requires surgical intervention. 5. Severe Haematuria. 6. Uncontrolled systemic disorders like Hypertension ( >160/100 mm-Hg), Diabetes Mellitus ( >180 mg/dl RBS). 7.Known cases of Cardiac disorders, Malignancy, Tuberculosis, HIV, VDRL, HepatitisB positive. 8. Pregnant and lactating mother. 9. Patients suffering from any auto immune diseases

Design outcomes

Primary

MeasureTime frame
Number of patients having complete excretion of renal stone on 28th day. â?¢ Reduction in size or number of stones as per X-ray & USG 0th day & 28th day.Timepoint: Zeroth day & 28th day

Secondary

MeasureTime frame
Improvement in signs & symptoms as per scoring pattern- on 0th, 7th, 14th, 21st, 28th day. â?¢ Biochemical investigations- CBC, RFT, LFT as safety parameters 0th day &28th day. â?¢ Urine analysis: Urine Routine & Microscopic- on 0th day &28th dayTimepoint: Zeroth day & 28th day

Countries

India

Contacts

Public ContactSreebala G

Institute of Teaching and Research in Ayurveda

brpayu@itra.edu.in7487876343

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026